Companies similar to ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Health Care · NASDAQ
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)'s closest peers include Alnylam Pharmaceuticals (ALNY), Ionis Pharmaceuticals (IONS), BridgeBio Pharma, Inc. (BBIO) and Regeneron Pharmaceuticals (REGN). This peer set is drawn from ARWR's enriched company profile and is informational only — not financial advice.
Similar companies
-
Alnylam PharmaceuticalsALNYHealth Care
Alnylam is a global leader in RNA interference therapeutics, pioneering a new class of genetic medicines to treat rare and serious diseases.
$271.37 (as of 2026-07-21) · market cap $36.2B
-
Ionis PharmaceuticalsIONSHealth Care
Pioneer in RNA-targeted antisense medicines with seven commercialized products and expanding late-stage pipeline across rare neurological and cardiometabolic…
$53.39 (as of 2026-07-21) · market cap $8.8B
-
BridgeBio Pharma, Inc.BBIOHealth Care
BridgeBio translates genetic science into medicines for rare genetic diseases through a decentralized portfolio model, with an FDA-approved lead product in…
$82.45 (as of 2026-07-21) · market cap $16.1B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$675.19 (as of 2026-07-21) · market cap $69.9B
Not quite? Describe exactly what you want →
Peers are drawn from ARWR's enriched profile (the same similarity signal the chat uses for "companies like ARWR"). See the full profile: ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.